Synthesis and evaluation of antibacterial activity of novel 3-methyl-1H-indazole derivatives

Farrukh Shaikh, Muhammad Arif, Mohammad Khushtar, Md Nematullah, Md Azizur Rahman
{"title":"Synthesis and evaluation of antibacterial activity of novel 3-methyl-1H-indazole derivatives","authors":"Farrukh Shaikh,&nbsp;Muhammad Arif,&nbsp;Mohammad Khushtar,&nbsp;Md Nematullah,&nbsp;Md Azizur Rahman","doi":"10.1016/j.ipha.2023.09.003","DOIUrl":null,"url":null,"abstract":"<div><p>Aim of the study was designed to synthesize and evaluate antibacterial activity of novel heterocyclic compounds, 3-methyl-1<em>H</em>-indazole derivatives. The heterocyclic compounds, 3-methyl-1<em>H</em>-indazole derivatives (<strong>1a-1d</strong> and <strong>2a-2d</strong>) were synthesized; all of them characterized physically by melting point, R<sub>f</sub> value, appearance &amp; solubility; and some of them characterized spectroscopically by IR and <sup>1</sup>H NMR spectroscopy. All the synthesized derivatives were evaluated for their antibacterial activity against both Gram positive bacteria, <em>Bacillus subtilis</em> and Gram negative bacteria, <em>Escherichia coli</em> by cup plate method using ciprofloxacin as a standard drug. All the synthesized heterocyclic compounds, 3-methyl-1<em>H</em>-indazole derivatives (<strong>1a-1d</strong> and <strong>2a-2d</strong>), had shown antibacterial activity against the <em>B. subtilis</em> and <em>E. coli</em>. Compound <strong>1d</strong> i.e., 1-(2-(piperidin-1-yl)ethan-1-oyl)-3-methyl-1<em>H</em>-indazole at the concentration of 300 ​μg/ml showed best antibacterial activity against the bacteria <em>B. subtilis</em> and <em>E. coli</em> as compared to standard drug, ciprofloxacin. The methodology for the synthesis of heterocyclic compounds, 3-methyl-1<em>H</em>-indazol-1-yl derivatives was simple as well as economical and gave better yield of the synthesized compounds. The compound, 1-(2-(piperidin-1-yl)ethan-1-oyl)-3-methyl-1<em>H</em>-indazole had shown best antibacterial activity against the bacteria <em>B. subtilis</em> and <em>E. coli</em>.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 12-16"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000795/pdfft?md5=5973eaa3e4c5fa76b7dda7f4e227ed56&pid=1-s2.0-S2949866X23000795-main.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949866X23000795","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Aim of the study was designed to synthesize and evaluate antibacterial activity of novel heterocyclic compounds, 3-methyl-1H-indazole derivatives. The heterocyclic compounds, 3-methyl-1H-indazole derivatives (1a-1d and 2a-2d) were synthesized; all of them characterized physically by melting point, Rf value, appearance & solubility; and some of them characterized spectroscopically by IR and 1H NMR spectroscopy. All the synthesized derivatives were evaluated for their antibacterial activity against both Gram positive bacteria, Bacillus subtilis and Gram negative bacteria, Escherichia coli by cup plate method using ciprofloxacin as a standard drug. All the synthesized heterocyclic compounds, 3-methyl-1H-indazole derivatives (1a-1d and 2a-2d), had shown antibacterial activity against the B. subtilis and E. coli. Compound 1d i.e., 1-(2-(piperidin-1-yl)ethan-1-oyl)-3-methyl-1H-indazole at the concentration of 300 ​μg/ml showed best antibacterial activity against the bacteria B. subtilis and E. coli as compared to standard drug, ciprofloxacin. The methodology for the synthesis of heterocyclic compounds, 3-methyl-1H-indazol-1-yl derivatives was simple as well as economical and gave better yield of the synthesized compounds. The compound, 1-(2-(piperidin-1-yl)ethan-1-oyl)-3-methyl-1H-indazole had shown best antibacterial activity against the bacteria B. subtilis and E. coli.

新型 3-甲基-1H-吲唑衍生物的合成与抗菌活性评价
本研究旨在合成和评估新型杂环化合物、3-甲基-1H-吲唑衍生物的抗菌活性。研究人员合成了杂环化合物、3-甲基-1H-吲唑衍生物(1a-1d 和 2a-2d),并通过熔点、Rf 值、外观 & 值和溶解度对所有衍生物进行了物理表征,还通过红外光谱和 1H NMR 光谱对其中一些衍生物进行了光谱表征。以环丙沙星为标准药物,采用杯板法评估了所有合成衍生物对革兰氏阳性菌枯草杆菌和革兰氏阴性菌大肠杆菌的抗菌活性。所有合成的杂环化合物、3-甲基-1H-吲唑衍生物(1a-1d 和 2a-2d)都对枯草杆菌和大肠杆菌具有抗菌活性。化合物 1d,即 1-(2-(哌啶-1-基)乙-1-酰基)-3-甲基-1H-吲唑,浓度为 300 微克/毫升,与标准药物环丙沙星相比,对枯草杆菌和大肠杆菌的抗菌活性最佳。合成杂环化合物、3-甲基-1H-吲唑-1-基衍生物的方法既简单又经济,而且合成化合物的收率较高。化合物 1-(2-(哌啶-1-基)乙-1-酰基)-3-甲基-1H-吲唑对枯草杆菌和大肠杆菌的抗菌活性最佳。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信